| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.57▲ | 3.56▲ | 3.54▲ | 3.87▼ | 5.01▼ |
| MA10 | 3.55▲ | 3.55▲ | 3.64▼ | 4.25▼ | 4.96▼ |
| MA20 | 3.51▲ | 3.70▼ | 3.84▼ | 5.46▼ | 3.23▲ |
| MA50 | 3.64▼ | 3.90▼ | 4.07▼ | 4.31▼ | 5.30▼ |
| MA100 | 3.85▼ | 4.23▼ | 5.19▼ | 2.95▲ | 6.09▼ |
| MA200 | 3.94▼ | 5.97▼ | 5.89▼ | 4.73▼ | 9.94▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.020▲ | 0.000▼ | -0.015▼ | -0.342▼ | 0.279▲ |
| RSI | 52.363▲ | 37.476▼ | 34.659▼ | 39.949▼ | 47.987▼ |
| STOCH | 76.881 | 48.086 | 21.626 | 8.475▼ | 25.871 |
| WILL %R | -11.111▲ | -52.113 | -74.627 | -94.236▼ | -86.638▼ |
| CCI | 80.648 | -15.194 | -67.754 | -108.362▼ | -10.494 |
|
Tuesday, April 28, 2026 05:47 AM
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...
|
|
Thursday, April 23, 2026 05:34 AM
View Artelo Biosciences Inc ARTL stock quote prices, financial information, real-time forecasts, and company news from CNN.
|
|
Monday, April 20, 2026 05:50 AM
Demonstrates ART26.12’s Differentiated Profile as a Promising Pain Treatment Ahead of Planned Multiple Ascending Dose Study This YearPhase 1 SAD ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/04/26 | 3.66 | 3.7191 | 3.37 | 3.57 | 686,035 |
| 27/04/26 | 4.02 | 4.12 | 3.68 | 3.77 | 296,650 |
| 24/04/26 | 4.21 | 4.23 | 4.00 | 4.035 | 233,370 |
| 23/04/26 | 3.92 | 4.12 | 3.85 | 3.99 | 393,049 |
| 22/04/26 | 3.77 | 4.2399 | 3.7298 | 4.00 | 619,029 |
| 21/04/26 | 4.05 | 4.30 | 4.03 | 4.05 | 563,492 |
| 20/04/26 | 5.12 | 5.6399 | 4.4801 | 4.525 | 32,664,314 |
| 17/04/26 | 4.73 | 4.86 | 4.40 | 4.44 | 94,327 |
| 16/04/26 | 5.10 | 5.11 | 4.18 | 4.86 | 441,376 |
| 15/04/26 | 5.30 | 5.4745 | 5.14 | 5.31 | 157,392 |
|
|
||||
|
|
||||
|
|